Sublingual apomorphine in PD: phase II results


Report from the 1st Congress of the European Academy of Neurology, Berlin, Germany, June 20-23, 2015 – Subcutaneous apomorphine is clinically available in many countries for the acute treatment of Off periods in PD. Alternative delivery methods have been investigated for several decades.

It takes 30 seconds

Recommend to a Colleague

Related Posts

Go back to home page